Journal profile · CELL BIOLOGY
NUCLEUS-INDIA
ISSN 0029-568X · eISSN 0976-7975 · Springer Nature
NUCLEUS-INDIA: CAS Zone 4 · Biology (2025 upgraded edition); impact factor 1.4 (journal website); subscription journal; APC about USD 3,190; median 146 days to acceptance (99 articles, last 24 months); 99 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
NUCLEUS-INDIA is published by Springer Nature and is in Zone 4 of Biology in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Chromosomal and Genetic Variations, Plant tissue culture and regeneration and Genetic diversity and population structure, together about 34.2% of its articles. Its main subfields are Plant Science and Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
The Nucleus is a peer-reviewed quarterly international journal publishing high-quality original research articles and reviews in the fields of cytogenetics and molecular biology. The journal aligns with the United Nations Sustainable Development Goals (SDGs), particularly SDG 2 (Zero Hunger), SDG 3 (Good Health and Well-Being), SDG 4 (Quality Education), SDG 7 (Affordable and Clean Energy), and SDG 15 (Life on Land), and promotes research that contributes to these global priorities through molecular, genetic, and cytological approaches. Focus areas include: • Molecular and cytogenetic research enhancing food security, nutritional quality, and sustainable agriculture, with emphasis on genetic improvement of crops and related species (SDG 2). • Studies advancing understanding of human diseases, diagnostics, and therapeutics, thereby supporting human health and well-being (SDG 3). • Development and dissemination of knowledge and resources that strengthen capacity-building and promote quality education in life sciences (SDG 4). • Interdisciplinary research and reviews on renewable and sustainable energy sources (SDG 7). • Genetic diversity, genotoxicity, genomics, proteomics, and metabolomics, encompassing both fundamental studies and applications towards biodiversity conservation and sustainable ecosystem use (SDG 15). • Molecular, cytogenetic, and genomic perspectives on evolutionary biology, species diversification, and epigenomic regulation, aimed at deepening our understanding of life’s complexity (SDG 15).
From the journal's Aims & Scope
Research area (LetPub): CELL BIOLOGY
Editor-in-chief Umesh C LavaniaPublisher website
Editorial board by country: 1 in mainland China (about 2%); most named India 23, United States 9, Japan 5, Australia 2, Mainland China 1 (46 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Chromosomal and Genetic VariationsAgricultural and Biological Sciences19.6%
- Plant tissue culture and regenerationBiochemistry, Genetics and Molecular Biology8%
- Genetic diversity and population structureBiochemistry, Genetics and Molecular Biology6.6%
- Plant Virus Research StudiesAgricultural and Biological Sciences4.7%
- Plant Genetic and Mutation StudiesAgricultural and Biological Sciences4.7%
- CRISPR and Genetic EngineeringBiochemistry, Genetics and Molecular Biology4.6%
- Genetic Mapping and Diversity in Plants and AnimalsBiochemistry, Genetics and Molecular Biology4.5%
- Plant Taxonomy and PhylogeneticsAgricultural and Biological Sciences4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Biology Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 4 |
| Minor | Cell Biology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Biology Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 4 |
| Minor | Cell Biology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
CASCAB AbstractsPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, AGRICOLA, Naver, OCLC, Portico, CLOCKSS
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 1.4Publisher website ·
- 5-year impact factor (publisher) 2025
- 2.8Publisher website ·
- CiteScore 2026-06
- 5.8LetPub ·
- SJR 2026-06
- 0.59LetPub ·
- SNIP 2026-06
- 1.1LetPub ·
- h-index
- 26OpenAlex ·
- i10-index
- 126OpenAlex ·
- 2-year mean citedness
- 1.73OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 4.78%LetPub ·
Volume
- Articles per year
- 97LetPub ·
- Downloads per year (publisher) 2025
- 95,400Publisher website ·
Articles by year OpenAlex count · 698 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 79 | 11 | 15 |
| 2025 | 99 | 4 | 116 |
| 2024 | 68 | 7 | 295 |
| 2023 | 47 | 6 | 189 |
| 2022 | 30 | 6 | 881 |
| 2021 | 38 | 8 | 628 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
146 daysMedian, submission to acceptance · P25–P75 97 days – 191 days
- Acceptance to online
- median 24 days (99 articles)
- Submission to online
- median 174 days
- Sample
- 99 articles with submission and acceptance dates (193 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Submission to first decision
- 12 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,190 / EUR 2,590 / GBP 2,290 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers1, by deadline
Publisher websiteWhat to prepare5 items from the author guidelines
- Abstract
- 150–250 words
- Keywords
- ≥ 4
- Manuscript length
- ≤ 3,500 words
- Reference style
- Numbered, in order of citation
- Suggested reviewers
- Optional, 4
Article types accepted3, with length limits
- editorialDouble-blind peer review This journal follows a double-blind reviewing procedure. This means that the author will remain anonymous to the reviewers throughout p…Length not stated
- full lengthFull Length (not exceeding 3500 words) Experimental procedures should give sufficient details for others to verify the work. Abstract should state the scope of …Length not stated
- reviewpal findings in no more than 250 words. Review (not exceeding 5000 words) A review should be comprehensive, up to date and criticalmain text ≤ 5,000 words
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, License & copyright, Open access, Peer review, Trial registration / reporting guidelines
- AI use Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Author Contributions Statement
Author contributions statement Model summary
Authors are expected to provide a short description of the contributions made by each listed author. This too will be published in a separate section after the Conflict of Interest statement. Back to top
Source ↗Publisher website ·- Conflicts of interest Conflict of Interest
Conflict of interest declaration Model summary
Conflicts may be financial, academic, commercial, political or personal. Financial interests may include employment, research funding (received or pending), stock or share ownership, patents, payment for lectures or travel, consultancies, nonfinancial support, or any fiduciary interest in a company. Authors must declare all such interests (or their absence) in writing upon submission of a manuscri…
Source ↗Publisher website ·- Data availability Data availability statements
Data availability statement required Model summary
All original research must include a data availability statement. This statement should explain how to access data supporting the results and analysis in the article, including links/citations to publicly archived datasets analysed or generated during the study. Please see our full policy here. If it is not possible to share research data publicly, for instance when individual privacy could be com…
Source ↗Publisher website ·- License & copyright Copyright
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under a Creative Commons license. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top
Source ↗Publisher website ·- Open access Open access publishing
Open Choice copyright Model summary
To find out more about publishing your work Open Access in The Nucleus, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Peer review Double-blind peer review
Double-blind peer review Model summary
This journal follows a double-blind reviewing procedure. This means that the author will remain anonymous to the reviewers throughout peer review. It is the responsibility of the author to anonymize the manuscript and any associated materials. Author names, affiliations and any other potentially identifying information should be removed from the manuscript text and any accompanying files (such as …
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer Nature
- ISSN
- 0029-568X
- Electronic ISSN
- 0976-7975
- Latest issue on the website
- Volume 69, Issue 3 (September 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about NUCLEUS-INDIA
What CAS zone is NUCLEUS-INDIA in?
In the 2025 upgraded edition of the CAS Journal Ranking, NUCLEUS-INDIA is in Zone 4 of Biology, and in Zone 4 of the minor category Cell Biology. In the 2026 Xinrui edition it is in Zone 4 of Biology. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of NUCLEUS-INDIA?
The journal's website gives an impact factor of 1.4 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 5.8, h-index 26.
How long does peer review take at NUCLEUS-INDIA?
Based on the dates recorded on 99 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 146 days (interquartile range 97–191 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of NUCLEUS-INDIA?
According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4; Manuscript length: ≤ 3,500 words; Reference style: Numbered, in order of citation; Suggested reviewers: Optional, 4. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of NUCLEUS-INDIA based?
Of the 46 board members whose country the journal's board page names, 1 (about 2%) are in mainland China; the countries named most often are India (23), United States (9) and Japan (5). Counted from the institutions listed on the board page; for reference only.
Which databases index NUCLEUS-INDIA?
According to LetPub and DOAJ records, NUCLEUS-INDIA is indexed in ESCI and Scopus. The journal's website also lists CAS and CAB Abstracts; that list has not been checked against each database.
Is NUCLEUS-INDIA open access, and what is the APC?
NUCLEUS-INDIA is a subscription journal. APC about USD 3,190.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .